Pharmacological Characterization of 4-Methylthioamphetamine Derivatives
Fabrizzio G. Guajardo, Victoria B. Velasquez, Daniela Raby, Gabriel Nunez-Vivanco, Patricio Iturriaga-Vasquez, Rodrigo A. Espana, Miguel Reyes-Parada and Ramon Sotomayor-Zarate
Amphetamine derivatives have been used in a wide variety of pathologies because of their pharmacological properties as psychostimulants, entactogens, anorectics, and antidepressants. However, adverse cardiovascular effects (sympathomimetics) and substance abuse problems (psychotropic and hallucinogenic effects) have limited their use. 4-Methylthioamphetamine (MTA) is an amphetamine derivative that has shown to inhibit monoamine uptake and monoamine oxidase. However, the pharmacological characterization (neurochemical, behavioral, and safety) of its derivatives 4-ethylthioamphetamine (ETA) and 4-methylthio-phenil-2-butanamine (MT-But) have not been studied. In the current experiments, we show that ETA and MT-But do not increase locomotor activity and conditioned place preference with respect to MTA. At the neurochemical level, ETA and MT-But do not increase in vivo DA release in striatum, but ETA and MT-But affect the nucleus accumbens bioaccumulation of DA and DOPAC. Regarding cardiovascular effects, the administration of MTA and ETA increased the mean arterial pressure and only ETA significantly increases the heart rate. Our results show that the pharmacological and safety profiles of MTA are modulated by changing the methyl-thio group or the methyl group of the aminoethyl chain.
Pharmacological Characterization of 4-Methylthioamphetamine Derivatives
Creators
Fabrizzio G. Guajardo - University of Valparaíso
Victoria B. Velasquez - University of Valparaíso
Daniela Raby - University of Valparaíso
Gabriel Nunez-Vivanco - University of Talca
Patricio Iturriaga-Vasquez - University of La Frontera
Rodrigo A. Espana - Drexel University
Miguel Reyes-Parada - University of Santiago Chile
Ramon Sotomayor-Zarate - University of Valparaíso
Publication Details
Molecules (Basel, Switzerland), v 25(22), p5310
Publisher
Mdpi
Number of pages
16
Grant note
120-0474; 117-0662 / National Agency of Research and Development (Chile) through FONDECYT
Nffi01/2006 / DIUV-CI Grant
DA031900; DA043787 / National Institute of Health (NIH); United States Department of Health & Human Services; National Institutes of Health (NIH) - USA
Resource Type
Journal article
Language
English
Academic Unit
Neurobiology and Anatomy
Web of Science ID
WOS:000594715400001
Scopus ID
2-s2.0-85096348350
Other Identifier
991019167940104721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool: